These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6931315)

  • 1. Parkinson's disease; acute urinary retention.
    Lieberman AN; Lebowitz A; Leibowitz M; Tessler A
    N Y State J Med; 1980 Jul; 80(8):1285-6. PubMed ID: 6931315
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurogenic dysfunction of the urinary bladder in Parkinson's disease.
    Foote J; Dejong JD
    Prim Care; 1977 Sep; 4(3):463-73. PubMed ID: 264223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurogenic bladder disturbances in Parkinson's disease (author's transl)].
    Schneider E; Patras L; Fischer PA
    Fortschr Neurol Psychiatr Grenzgeb; 1978 May; 46(5):260-8. PubMed ID: 248041
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of subthalamic deep brain stimulation on the function of the urinary bladder.
    Seif C; Herzog J; van der Horst C; Schrader B; Volkmann J; Deuschl G; Juenemann KP; Braun PM
    Ann Neurol; 2004 Jan; 55(1):118-20. PubMed ID: 14705120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Disturbance of micturition in Parkinson's disease].
    Sakakibara R; Uchiyama T; Yoshiyama M; Hattori T
    No To Shinkei; 2001 Nov; 53(11):1009-14. PubMed ID: 11761908
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical findings of neurogenic bladder in patients with Parkinson's disease, multiple sclerosis and spinocerebellar degeneration].
    Shimizu K; Yasukawa M; Yamamoto M; Hirao Y; Momose H; Kashiwai H; Kawata Y; Yamada K
    Hinyokika Kiyo; 1997 Nov; 43(11):765-9. PubMed ID: 9436018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tibial neuromodulation in the treatment of neurogenic detrusor hyperactivity in patients with Parkinson's disease].
    Krivoborodov GG; Gekht AB; Korshunova ES
    Urologiia; 2006; (4):3-6. PubMed ID: 17058670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute urodynamic effects of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson's disease.
    Kabay SC; Kabay S; Yucel M; Ozden H
    Neurourol Urodyn; 2009; 28(1):62-7. PubMed ID: 18837432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the vesicourethral function between progressive supranuclear palsy and Parkinson's disease].
    Wakatsuki A; Tsujihata M; Miyake O; Ito H; Itatani H; Udaka F
    Hinyokika Kiyo; 1993 Jun; 39(6):523-8. PubMed ID: 8337978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Parkinson's disease and associated disorders].
    Tison F; Ghorayeb I
    Rev Prat; 2005 Apr; 55(7):741-7. PubMed ID: 15966417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation and management of the urologic consequences of neurologic disease.
    Kotkin L; Milam DF
    Tech Urol; 1996; 2(4):210-9. PubMed ID: 9085542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign prostatic obstruction and parkinson's disease--should transurethral resection of the prostate be avoided?
    Roth B; Studer UE; Fowler CJ; Kessler TM
    J Urol; 2009 May; 181(5):2209-13. PubMed ID: 19296974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative assessment of combined therapy of neurogenic hyperactivity of detrusor in patients with Parkinson's disease].
    Loran OB; Fedorova NV; Mazurenko DA; Khitarishvili EV
    Urologiia; 2006; (2):37-9, 41. PubMed ID: 16708587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower urinary tract symptoms in dementia with Lewy bodies, Parkinson disease, and Alzheimer disease.
    Ransmayr GN; Holliger S; Schletterer K; Heidler H; Deibl M; Poewe W; Madersbacher H; Kiss G
    Neurology; 2008 Jan; 70(4):299-303. PubMed ID: 18209204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary retention associated with herpes zoster.
    Ray B; Wise GJ
    J Urol; 1970 Sep; 104(3):422-5. PubMed ID: 5459977
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of subthalamic nucleus stimulation on urodynamic findings in patients with Parkinson's disease.
    Finazzi-Agrò E; Peppe A; D'Amico A; Petta F; Mazzone P; Stanzione P; Micali F; Caltagirone C
    J Urol; 2003 Apr; 169(4):1388-91. PubMed ID: 12629368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of hyperammonemia resulting from urinary tract infection caused by urease-producing bacteria in a Parkinson's disease patient with drug-induced urinary retention].
    Yasunishi M; Koumura A; Hayashi Y; Nishida S; Inuzuka T
    Nihon Ronen Igakkai Zasshi; 2017; 54(4):560-566. PubMed ID: 29212999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary disturbances in striatonigral degeneration and Parkinson's disease: clinical and urodynamic aspects.
    Bonnet AM; Pichon J; Vidailhet M; Gouider-Khouja N; Robain G; Perrigot M; Agid Y
    Mov Disord; 1997 Jul; 12(4):509-13. PubMed ID: 9251068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vesical sphincter disorders in Parkinson disease].
    Aranda B
    Rev Neurol (Paris); 1993; 149(8-9):476-80. PubMed ID: 8009145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
    Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A
    J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.